Miguel Sieler

Miguel Sieler was the founder of Abivax SA, serving as Director from 2003 to 2015.
Mr. Sieler is currently President & Director at Neovacs, Inc. Former positions include Chief Executive Officer & Director at Neovacs SA from 2013 to 2019, Chief Executive Officer at Bayer Pharma France SA, Chairman-Supervisory Board at Haarmann & Reimer Corp, Deputy Chairman-Supervisory Board at Borchers SAS, Chairman at Wittycell SAS from 2009 to 2014, Chairman-Supervisory Board at Bayer Sante Familiale SAS, Chairman-Management Board at Bayer SAS, Chairman-Supervisory Board at Bayer Sante, Chairman-Supervisory Board at ARLANXEO Elastomères France SAS, Chairman at Demeta SAS, Chairman at Natchem SASU, Director at Ethypharm SAS, Independent Director at Nexity SA from 2012 to 2016, Director at Fondation de la Maison de la Chimie, Director at Bayer Environmental Science SAS, Director at Bayer Immobilier, Director at Bayer HealthCare Ltd., Member-Supervisory Board at Bayer CropScience SA, President at Plasmaprime SAS from 2010 to 2012, Member-Supervisory Board at Lanxess SAS, and Venture Partner at Truffle Capital SAS from 2011 to 2016.
Education includes a graduate degree from Eberhard Karls Universität Tübingen and an undergraduate degree from Sciences Po.